Open AccessS141: ELICITING ANTI‐TUMOR T CELL ACTIVITY IN CHRONIC LYMPHOCYTIC LEUKEMIA WITH BISPECIFIC ANTIBODY‐BASED COMBINATION THERAPY
Author(s) -
Papazoglou D.,
Ysebaert L.,
Ioannou N.,
Apollonio B.,
Patten P.,
Herter S.,
Bacac M.,
Deutsch A.,
Klein C.,
Vardi A.,
QuilletMary A.,
Ramsay A.
Publication year - 2022
Publication title -
hemasphere
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.677
H-Index - 11
ISSN - 2572-9241
DOI - 10.1097/01.hs9.0000843456.05456.f5
Subject(s) - chronic lymphocytic leukemia , cd8 , cd20 , t cell , immunology , tumor microenvironment , cytotoxic t cell , medicine , immune system , cancer research , immunotherapy , ibrutinib , antibody , leukemia , biology , in vitro , biochemistry